The Ministry of Health of the United Republic of Tanzania has officially invited local and international investors to establish or expand pharmaceutical manufacturing facilities in the country.
The initiative is part of the government’s strategy to reduce reliance on imported medicines and secure a reliable supply of essential pharmaceuticals for Tanzanians.
The government is prioritizing the production of essential medicines, vaccines, biologics, Active Pharmaceutical Ingredients (APIs), medical consumables, and specialized formulations such as oncology treatments and biosimilars.
To fast-track this process, the Expression of Interest (EOI) is being conducted under a Green-Lane Approval System, offering investors accelerated regulatory approvals and coordinated government support.
Investment opportunities include the development of new greenfield plants, modernization of existing facilities, joint ventures, and technology transfer initiatives.
Investors will benefit from a comprehensive package of incentives under the Tanzania Investment Act, including fiscal and non-fiscal support, access to industrial and special economic zones, assistance with land acquisition, and opportunities for long-term procurement agreements with the government.
Interested parties are required to demonstrate technical expertise, financial capacity, and experience in large-scale industrial projects, with particular emphasis on compliance with WHO-GMP standards.
Submissions should provide a detailed company profile, proposed investment areas and production capacity, indicative capital outlay with a financing plan, implementation timeline, and legal compliance statements.
All submissions must reach the Ministry of Health by 16:00 East Africa Time on March 2, 2026, either electronically or in hard copy, and should be addressed to the Permanent Secretary at P.O. Box 743, 40478 Dodoma.
Each submission must be clearly marked: “Expression of Interest – Pharmaceutical Manufacturing in Tanzania.”
This pre-qualification stage will identify eligible firms, who will then be invited to participate in the subsequent Request for Proposal (RFP) process.
The Ministry of Health encourages all qualified investors to take part in this transformative initiative aimed at strengthening Tanzania’s pharmaceutical industry and improving access to essential medicines.